U.S. Court Overturns $452 Million Trade Secret Verdict Against Insulet

What’s happening

A U.S. appeals court overturned a $452 million verdict against Insulet Corporation involving alleged insulin pump trade-secret theft.

The earlier ruling had favored a rival company, but the appeals court reversed the decision.

What’s changing / Business impact

• Major legal relief for Insulet
• Reduced financial liability
• Continued competition in insulin-device technology
• Ongoing intellectual-property battles in medtech

Why this matters

Insulin pump systems are a rapidly growing part of diabetes treatment.